1. Introduction {#sec0005}
===============

Group A rotaviruses are well established as the major cause of acute viral gastroenteritis in infants and young children worldwide. Rotaviruses belong to the *Reoviridae* family and possess a genome of 11 segments of double-stranded RNA (dsRNA). The binomial classification system for rotaviruses is based on the two outer capsid proteins, VP7 (G genotype) and VP4 (P genotype) ([@bib0065]). At least 27 G and 35 P genotypes have been designated for human and animal strains ([@bib0155]). Five strains, G1P1A\[8\], G2P1B \[4\], G3P1A\[8\], G4P1A\[8\], and G9P1A\[8\] are the globally predominant human pathogens ([@bib0080]) and have been targeted in vaccine development.

Two live-attenuated oral vaccines, RotaTeq^®^ (Merck, Whitehouse Station, NJ, USA) and Rotarix^®^ (GlaxoSmithKline, Research Triangle Park, NC, USA) have been introduced into childhood immunization programs in the United States and other countries ([@bib0085]). RotaTeq^®^ is a pentavalent human-bovine reassortant rotavirus vaccine that includes genes of human rotavirus serotypes G1--G4 and P1A\[8\]. Rotarix^®^ vaccine is a monovalent vaccine derived from a G1P1A\[8\] human rotavirus strain. Transmission and shedding of rotavirus vaccine strains has been reported ([@bib0040], [@bib0175], [@bib0225], [@bib0265]).

To monitor circulating rotavirus serotypes before and after vaccine introduction, including any possible emerging or novel strains post-vaccine introduction, many countries conduct regional rotavirus strain surveillance programs. In the United States, surveillance by the Centers for Disease Control and Prevention (CDC), in collaboration with laboratories of the National Rotavirus Strain Surveillance System (NRSSS) ([@bib0100], [@bib0210]), and the New Vaccine Surveillance Network ([@bib0180]), has been ongoing since 1996 and 2006, respectively.

Rotavirus strain surveillance programs typically use reverse transcription-polymerase chain reaction (RT-PCR)-based methods to determine rotavirus genotypes directly from RNA extracted from stool specimens ([@bib0030], [@bib0075], [@bib0090]) and rotavirus detection by real time RT-PCR (qRT-PCR) is increasing in use ([@bib0070]). Fecal samples are among the most difficult clinical samples to process because of the presence of very potent inhibitors of nucleic acid amplification such as complex polysaccharides, bilirubin and bile salts ([@bib0020], [@bib0165], [@bib0170]). Difficulty in eliminating RT-PCR inhibitors from stool extracts has been reported extensively ([@bib0135], [@bib0150], [@bib0165], [@bib0190]). Inhibitory effects can be reduced by adding amplification facilitators such as bovine serum albumin to the PCR reaction ([@bib0130]), using thermostable polymerases that are more resistant to PCR inhibition ([@bib0005]), or using more efficient processes for extracting nucleic acid from stool samples. The efficiency of nucleic acid extraction and purification influences the sensitivity, reproducibility and the accuracy of RT-PCR target detection ([@bib0140]). During the last 10 years, several new manual, semi-automated and automated commercial nucleic acid or RNA extraction systems using magnetic beads or silica particles have been developed for DNA, RNA or total nucleic acid extraction which are attractive due to their flexibility, convenience, and ease of use ([@bib0240]). A small number of studies have compared some of these novel extraction methods and reported that they differ in their ability to recover viral RNA, indicating that no single RNA extraction method is optimal for all viruses ([@bib0010], [@bib0105], [@bib0125], [@bib0190]).

The most recent study comparing nucleic acid extraction methods for rotavirus detection in stool was published in 2002 ([@bib0215]). Since then, a number of new nucleic acid extraction systems using magnetic beads or silica particles have been developed, both in automated and manual formats ([@bib0050], [@bib0185], [@bib0235], [@bib0245]). Although some of these extraction systems have been used extensively for the extraction of rotavirus RNA from stool and other clinical and environmental samples ([@bib0015], [@bib0035], [@bib0055], [@bib0060], [@bib0070], [@bib0110], [@bib0160], [@bib0195], [@bib0200], [@bib0205], [@bib0270]), they have not been evaluated formally to determine which method is most efficient for extraction of rotavirus RNA.

The objective of this study was to identify the best commercially-available nucleic acid extraction method for preparing stool samples for detection of rotaviruses by both conventional RT-PCR and qRT-PCR. This information will be very useful for rotavirus surveillance programs, diagnostics, and epidemiologic studies.

2. Materials and methods {#sec0010}
========================

2.1. Stool samples {#sec0015}
------------------

Eight rotavirus positive stool samples with optical density (OD) values ranging from 0.176 to 3.098, as determined by enzyme immunoassay (EIA) (Premier™ RotaClone^®^, Meridian Bioscience, Cincinnati, OH, USA), were used to prepare 10% suspensions in phosphate-buffered saline solution. These samples (5627:EIA OD = 0.854, genotype G2P\[4\]; 5628:OD = 0.176, G2P\[4\]; 5629:OD = 0.547, G2P\[4\]; 5630:OD = 3.098, G4P\[8\]; 5631:OD = 2.075, G4P\[8\]; 5633:OD = 1.768, G2P\[4\]; 5634:OD = 0.318, G1P\[8\]; and 5635:OD = 0.315, G1P\[8\]) were collected in Nicaragua during the 2009 rotavirus season.

2.2. Extraction methods {#sec0020}
-----------------------

Six commercial extraction methods for total nucleic acid or RNA were evaluated: the automated MagNA Pure Compact (Roche Applied Science, Indianapolis, IN, USA), KingFisher Flex-96 (ThermoFisher, Pittsburgh, PA, USA), and NucliSENS^®^ easyMAG^®^ (BioMerieux, Durham, NC, USA) methods; the semi-automated NucliSENS^®^ miniMAG^®^ (BioMerieux, Durham, NC, USA); and the manual QIAamp Viral RNA mini kit (Qiagen, Valencia, CA, USA) and RNaid^®^ kit (Qbiogene, Carlsbad, CA, USA) with a modified protocol) ([Table 1](#tbl0005){ref-type="table"} ). Each extraction method was chosen because it had been used previously in studies for the extraction of nucleic acid from stool. The MagNA Pure LC instrument has been used to purify nucleic acid from many types of clinical specimens including stool samples for rotavirus ([@bib0025], [@bib0190], [@bib0230], [@bib0250], [@bib0255]) but is no longer in production so the MagNA Pure Compact instrument, which uses the same paramagnetic bead technology, was evaluated instead. The MagNA Pure Compact was used with the MagNA Pure Compact RNA Isolation Kit (Roche Applied Science Indianapolis, IN, USA). The easyMAG and miniMAG extraction platforms utilize the same silica extraction technology and use the same reagents. Both methods are universal and can be applied to a broad range of different specimens such as blood, sputum, serum, throat swabs and stool ([@bib0045], [@bib0070], [@bib0145], [@bib0185], [@bib0245]). Both methods have been used for extraction of rotavirus RNA from stool ([@bib0110]). The easyMAG and miniMAG are mainly used in laboratories that require moderate- and low-throughput, respectively ([@bib0260]). The KingFisher Flex (96 deep well magnet head) designed for high throughput laboratories, is an automated extractor also used for rotavirus RNA extraction ([@bib0070], [@bib0095], [@bib0110]). In this study it was used with the MagMax™-96 Total RNA Isolation Kit (Applied Biosystems, Foster City, CA, USA). The QIAamp Viral RNA Mini kit, which is based on silica membrane technology, has been used extensively for the extraction of rotavirus RNA from stool ([@bib0035], [@bib0160], [@bib0200], [@bib0205], [@bib0270]).Table 1Commercial extraction methods compared in this study.InstrumentKitVendorCore TechnologyMode of extractionExtracted productSample vol. processed (μl)Elution vol. (μl)Not applicableRNaid^®^ RNA extraction KitQbiogene Carlsbad, CAGlass powderManualRNA[a](#tblfn0005){ref-type="table-fn"}20050Not applicableQIAamp Viral RNA Mini KitQiagen Valencia, CASilica membraneManualRNA[a](#tblfn0005){ref-type="table-fn"}14060MagNa Pure CompactMagNA Pure Compact RNA Isolation KitRoche Applied Science Indianapolis, IN ThermoFisherMagnetic beadsAutomatedRNA100100KingFisher Flex 96MagMax™-96 Total RNA Isolation KitPittsburgh, PAMagnetic beadsAutomatedRNA[a](#tblfn0005){ref-type="table-fn"}5075NucliSENS\
easyMAG^®^NucliSENS Nucleic Acid extraction Reagents for easyMAG^®^BioMerieux Durham, NCMagnetic beadsAutomatedTNA[b](#tblfn0010){ref-type="table-fn"}20055NucliSENS^®^ miniMAG^®^NucliSENS^®^ Nucleic Acid extraction Reagents for miniMAG^®^BioMerieux Durham, NCMagnetic beadsSemi-automatedTNA[b](#tblfn0010){ref-type="table-fn"}20050[^1][^2]

The RNaid kit extraction protocol, which uses glass powder to capture and purify rotavirus RNA, has been modified and used by the CDC Rotavirus Surveillance Laboratory routinely since the 1990\'s along with other methods to extract rotavirus RNA from stool ([@bib0075], [@bib0120]). In brief, 200 μL of clarified 10% stool suspension was mixed directly with 400 μL 6 M guanidine thiocyanate (Ultrapure Grade; Boehringer Mannheim, Germany) and 10 μL of RNAID glass powder. The mixture was then vortexed and mixed on a Nutator rocker (Clay Adams Division, Becton-Dickinson, Parsippany, NJ, USA) for 15 min at room temperature. Each sample was then centrifuged for 60 s at 650 ×  *g* and the supernatant was removed by aspiration with a Pasteur pipette. The samples were washed once with 700 μL of guanidine thiocyanate wash solution (4 M guanidine thiocyanate, 16.7 mM Tris--HCl, pH 7.5) and centrifuged at 850 ×  *g* for 60 s. The supernatant was aspirated and the samples were then washed two times with 400 μL of the RNAID kit wash buffer and centrifuged at 850 ×  *g* for 60 s. The supernatant was aspirated, and the samples were washed once more with the same buffer and were then finally centrifuged at 10,000 ×  *g* for 120 s. After aspiration of the supernatant, the samples were dried at room temperature for 1 h, resuspended in 35 μL of nuclease free water, and incubated for 10 min at 65 °C. The samples were centrifuged at 10,000 ×  *g* for 120 s, and the supernatant was transferred to microcentrifuge tubes (Lube Tube; Marsh Co., Rochester NY, USA). The pellet was re-extracted with the same volume of water (35 μL), and the combined supernatants were stored at −80 °C until they were used. Immediately before use for PCR, the supernatants were incubated at 56 °C for 5 min and were then centrifuged at 10,000 ×  *g* for 60 s to pellet the residual RNAID from the sample.

With the exception of the RNaid kit as described, extractions were performed according to kit and instrument protocols. Single aliquots of each stool suspension and a negative control stool were extracted in triplicate by each method.

2.3. qRT-PCR {#sec0025}
------------

The total nucleic acid or RNA extracts were amplified in duplicate by rotavirus NSP3 gene qRT-PCR ([@bib0070]) modified for use on ABI 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) with the 7500 Fast SDS software v1.4.0. No-template and positive controls were included in each run. All assays were run using the standard mode on the ABI 7500 Fast instrument. Before beginning the TaqMan cycling conditions, each RNA extract was first denatured in a thermocycler at 95 °C for 5 min followed by a 1 min incubation on ice. The thermocycling program used was 30 min reverse transcription at 50 °C (1 cycle), followed by a 15 min enzyme deactivation step at 95 °C (1 cycle), and 45 cycles of amplification that consisted of denaturation at 95 °C for 15 s and annealing and extension at 60 °C for 1 min.

To test for potential carryover of RT-PCR inhibitors from the stool samples into total nucleic acid or RNA extracts, extracts from three stool samples were diluted 1:10 in nuclease free water and re-tested in duplicate by qRT-PCR as previously described by [@bib0190].

2.4. Comparison of dilution series extracts by conventional RT-PCR and qRT-PCR {#sec0030}
------------------------------------------------------------------------------

A 10% suspension prepared from stool sample with a high viral concentration (OD value 3.098) was serially diluted 10^−1^--10^−7^ in a rotavirus-negative stool suspension and then re-tested by EIA. Total nucleic acid or RNA was extracted by each of the six methods and tested by VP6 RT-PCR and NSP3 qRT-PCR ([@bib0070], [@bib0115]). For the real-time assay, each dilution was tested in duplicate and the average threshold cycle (C~t~) value for each reaction was calculated. VP6 RT-PCR amplicons were detected by electrophoresis of the amplified products through 1% agarose gels containing GelRed (Biotium, Heyward, CA, USA) and RT-PCR products were detected under UV transillumination.

2.5. Cost and time analysis {#sec0035}
---------------------------

Extraction cost per sample was estimated using the 2012 manufacturer price of each extraction kit or reagents. Hands-on time for the MagNA Pure Compact system, miniMAG system, RNaid kit, and QIAamp Viral RNA Mini was measured as time per sample when eight extractions were performed in parallel. Also, the easyMAG and KingFisher Flex systems were timed using a run of eight samples. For all methods, operator\'s hands-on time was measured as the total time to perform each step in the extraction process. Total time to completion (hands-on and hands-off) was determined by timing a complete run on each instrument, from the addition of the first reagent to the recovery of the RT-PCR-ready nucleic acid.

2.6. Statistical analysis {#sec0040}
-------------------------

Prism Version 5.02 Software for Windows (GraphPad Software, La Jolla, CA) was used to plot *C* ~t~ values. To determine whether the differences in *C* ~t~ values for nucleic acid extracts prepared using each extraction method were significant, *C* ~t~ values were compared using the Friedman test. When significant differences were identified, Dunn\'s Multiple Comparison Test was used to perform nonparametric pairwise analyses of *C* ~t~ values.

3. Results {#sec0045}
==========

3.1. Comparison of extraction methods by qRT-PCR {#sec0050}
------------------------------------------------

When qRT-PCR results were compared for all six extraction methods, samples extracted by using the MagNA Pure Compact system yielded the lowest average *C* ~t~ values for 6 of 8 stools, including the 5 highest concentration samples as determined at EIA; the RNaid performed best with the other two samples which were among the 3 lowest concentration samples as determined by EIA ([Fig. 1](#fig0005){ref-type="fig"} ). Statistical analysis of method-to-method variability detected significant differences among the mean *C* ~t~ values for all nucleic acid extracts obtained using the 6 methods (*P*  \< 0.001). When pairwise analyses of extraction method data were performed, the mean *C* ~t~ values for KingFisher Flex extracts were significantly higher than those of the best performing method (MagNA Pure Compact or RNaid kit) for 7 of 8 samples as was the case for the QIAamp Viral RNA Mini kit with 6 samples ([Fig. 1](#fig0005){ref-type="fig"}). In the case of 4 samples (5630, 5631, 5627, 5629) where the MagNA Pure Compact extracts yielded the lowest mean *C* ~t~ values, the values for the RNaid kit were significantly higher ([Fig. 1](#fig0005){ref-type="fig"}). In the two cases where the RNaid kit extracts yielded the lowest mean *C* ~t~ values (samples 5634 and 5628), the mean *C* ~t~ values for the MagNA Pure Compact extracts were not significantly different. With 2 samples (5634, 5635), the mean *C* ~t~ values for miniMAG extracts were significantly higher than the best performing method. The mean *C* ~t~ values for the easyMAG were never the lowest but never differed significantly from the best performing method.Fig. 1Scatter plots showing the distribution of *C*~t~ values obtained using RNA or total nucleic acid prepared from eight rotavirus samples using six different extraction protocols. The horizontal line in each group of observed values for a method corresponds to the mean value. Sample ID and OD values (in parentheses) are indicated above each scatter plot graph. T-bars indicate the standard deviation of the mean. The best performing method for each sample labeled with ★. Methods with mean *C*~t~ values that were found to be significantly higher than the best performing method are labeled with \*(*P* \< 0.05), \*\*(*P* \< 0.01), or \*\*\*(*P* \< 0.001).

Inhibitors were detected in extracts prepared with the QIAamp Viral RNA Mini kit; the 1:10 dilutions of each QIAamp Viral RNA Mini kit extract exhibited lower *C* ~t~ values than the undiluted extract ([Table 2](#tbl0010){ref-type="table"} ), with average *C* ~t~ values decreasing 1.3--2.5 cycles. The 1:10 dilutions of the extracts prepared using the other extraction methods showed increases in *C* ~t~ values by 2--4 cycles, consistent with a dilution effect of target RNA.Table 2Mean and standard deviations (SD) of *C*~t~ values obtained by quantitative reverse transcriptase PCR using undiluted and 1:10 dilutions of rotavirus RNA/TNA extracts from 3 stool samples.SampleOD valueRNaidQIAamp Viral RNAMagNA Pure CompactKingFisher Flex 96NucliSENS easyMAGNucliSENS miniMAGOriginal1:10Original1:10Original1:10Original1:10Original1:10Original1:10Mean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SD56280.17620.3 ± 0.12424.23 ± 0.0423.5 ± 0.0221.0 ± 0.0822.09 ± 0.7924.88 ± 0.0523.13 ± 0.0526.52 ± 0.0622.06 ± 0.0424.84 ± 0.222.48 ± 0.0725.13 ± 0.0556270.85417.21 ± 0.0619.48 ± 0.0416.0 ± 0.0214.7 ± 0.0316.3 ± 0.6619.15 ± 0.0616.97 ± 0.0720.62 ± 0.0316.93 ± 0.0619.08 ± 0.0317.24 ± 0.0319.61 ± 0.0456303.09815.38 ± 0.0418.35 ± 0.0217.7 ± 0.0415.5 ± 0.0615.3 ± 0.4817.53 ± 0.0615.19 ± 0.0217.73 ± 0.114.64 ± 0.0516.17 ± 0.0715.21 ± 0.0317.14 ± 0.04

3.2. Comparison of dilution series extracts by conventional RT-PCR and qRT-PCR {#sec0055}
------------------------------------------------------------------------------

Extracts from serially diluted stool samples were analyzed for the presence of the template using VP6 RT-PCR ([@bib0115]) and the NSP3 qRT-PCR assay ([@bib0070]). For the conventional RT-PCR assay, analysis by gel electrophoresis revealed a single band of the expected size for all rotavirus samples ([Fig. 2](#fig0010){ref-type="fig"} ). MagNA Pure Compact and KingFisher Flex were the only platforms capable of producing amplifiable template from all 7 dilutions (10^−1^--10^−7^). The QIAamp Viral RNA kit, and miniMAG systems yielded amplifiable template in 5 out of the 7 dilutions (10^−1^--10^−5^). The RNaid^®^ kit and easyMAG^®^ system yielded template with the poorest level of detection with template detected in the first 3 dilutions (10^−1^--10^−3^) only. With the qRT-PCR, the *C* ~t~ values obtained with each method increased with each sample dilution and all rotavirus RNA was detected in all dilutions for all six extraction methods ([Table 3](#tbl0015){ref-type="table"} ) but there were significant differences in *C* ~t~ values among the six methods (*P*  \< 0.0001). *C* ~t~ values obtained from extracts prepared using the RNaid^®^ kit were significantly lower than those obtained for the easyMAG^®^, miniMAG^®^, and QIAamp Viral Mini RNA kit extracts ([Table 3](#tbl0015){ref-type="table"}). Extracts prepared using the KingFisher Flex yielded *C* ~t~ values that were significantly lower than those obtained from easyMAG^®^ and miniMAG^®^ extracts ([Table 3](#tbl0015){ref-type="table"}). *C* ~t~ values obtained from extracts prepared using the MagNA Pure Compact were significantly lower than those obtained for the miniMAG^®^ ([Table 3](#tbl0015){ref-type="table"}). Extracts prepared using the RNaid^®^ kit, MagNA Pure Compact and KingFisher Flex did not differ significantly ([Table 3](#tbl0015){ref-type="table"}).Fig. 2Gels showing limit of detection of rotavirus VP6 gene fragment (379 bp) by conventional RT-PCR using RNA or total nucleic acid extracted from a stool sample containing a high concentration of rotavirus (EIA OD value = 3.0) diluted 10^−1^--10^−7^ in a negative stool suspension, by each extraction method. A = MagNA Pure Compact, B = KingFisher Flex, C = QIAamp Viral RNA, D= miniMAG^®^, E = easyMAG^®^ and F = RNaid^®^. MM = 100 bp Plus DNA Ladder.Table 3Mean and standard deviation (SD) of *C*~T~ values obtained by qRT-PCR using TNA or RNA extracted from a stool sample with a high viral concentration diluted 10^−1^ to 10^−7^ in a negative stool sample by each extraction method.DilutionOD valueRNaid[a](#tblfn0015){ref-type="table-fn"}MagNA Pure Compact[b](#tblfn0020){ref-type="table-fn"}NucliSENS miniMAGNucliSENS easyMAGKingFisher Flex[c](#tblfn0025){ref-type="table-fn"}QIAamp Viral RNAMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SD10^−1^2.8113 ± 0.0913.4 ± 0.2317.3 ± 0.0115.3 ± 0.1812 ± 0.0312.3 ± 0.1110^−2^1.5117 ± 0.0317.4 ± 0.3419.5 ± 0.0818.8 ± 0.0117.3 ± 0.1318 ± 0.0410^−3^0.3220 ± 0.2020.5 ± 0.0722.3 ± 0.0421.4 ± 0.2220.7 ± 0.9621.2 ± 0.1310^−4^0.1023.1 ± 0.1123.3 ± 0.0625.8 ± 0.0824.5 ± 0.2323.6 ± 0.2924 ± 0.0110^−5^0.0824.9 ± 0.0227 ± 0.2127.4 ± 0.0728.1 ± 0.2225.6 ± 0.1728.2 ± 0.0910^−6^0.0828.4 ± 0.1728.6 ± 0.0731.6 ± 0.1231.4 ± 0.1230 ± 0.0831.6 ± 0.5110^−7^0.0729 ± 0.0133.7 ± 0.1933.2 ± 0.1134.6 ± 0.4033.3 ± 0.2433.2 ± 0.24[^3][^4][^5]

3.3. Cost and time analysis {#sec0060}
---------------------------

The total extraction time for 8 samples ranged from approximately 40 min for QIAamp Viral RNA Mini kit and KingFisher Flex to approximately 110 min for the RNaid kit ([Table 4](#tbl0020){ref-type="table"} ). The RNaid kit had the lowest cost/per sample and MagNA Pure Compact was the most expensive. The KingFisher Flex had the highest sample throughput (up to 96 samples/run).Table 4Total time and cost per extraction.Instrument/KitTotal time (min)Hands-on time (min)Hands-off time (min)Cost per extraction (US \$)[a](#tblfn0030){ref-type="table-fn"}Extraction per runRNaid∼110∼50∼600.87n/aQIAamp Viral RNA Mini Kit∼40∼30∼103.94n/aMagNa Pure Compact∼80∼20∼6010.758KingFisher Flex 96∼85∼55∼303.4896easyMAG∼71∼25∼468.8424miniMAG∼72∼57∼156.312[^6]

4. Discussion {#sec0065}
=============

Evaluation of the six commercial extraction platforms using stool samples indicated that the MagNA Pure Compact performed best for isolating rotavirus RNA that could be amplified by both conventional RT-PCR and qRT-PCR. No PCR inhibitors were detected in the extracts, which most often yielded the lowest *C* ~t~ values. Although it is the most costly, this method was the most consistent and had relatively low hands-on and hands-off time processing time. Without knowledge of the proprietary components of the kit used with MagNA Pure Compact RNA Isolation kit, the reason for its superior performance cannot be determined. However, a possible explanation is that the method uses silica-coated magnetic beads, and the extraction process includes a DNase treatment step. The easyMAG, miniMAG and KingFisher Flex methods also use magnetic beads but without a DNase treatment step. The *C* ~t~ values for extracts obtained using these methods were always higher but the extracts were not found to contain inhibitors of RT-PCR. The easyMAG and miniMAG extraction platforms are total nucleic acid extraction methods, suggesting that DNA in the extracts may have interfered with the extraction process or RT-PCR. The KingFisher Flex is an RNA only extraction method, but without a DNase treatment step the extracted product is likely to be contaminated with DNA. Therefore, the sub-optimal performance of the KingFisher Flex may be a function of the small volume of sample processed (50 μL) as well as the presence of DNA in the extract.

The QIAamp Viral Mini RNA kit yielded extracts with mean *C* ~t~ values which were significantly higher than the best performing method with 6 samples. This study showed that use of the QIAamp Viral RNA Mini kit can lead to carryover of RT-PCR inhibitors for rotavirus RNA detection, since the 1:10 dilution of extracts lowered the *C* ~t~ values. Detection of partial amplification inhibition has been reported for stool samples extracted using the QIAamp Viral RNA kit when stool extracts were tested for SARS coronavirus RNA ([@bib0190]). The rest of the extraction methods showed no notable inhibition, only an expected dilution effect which results in an increase in *C* ~t~ values.

When a dilution series of rotavirus positive stool diluted in a negative stool was extracted by each of the six methods and then tested by qRT-PCR, rotavirus RNA was detected in all samples. When each set of extracts from the dilution series was tested by conventional RT-PCR assays, however, only the MagNA Pure Compact and KingFisher Flex extracts were able to yield a detectable product in all seven dilutions. This observation could be the result of differences in amplicon size between the two methods, 91 base-pairs for qRT-PCR versus 379 bp for conventional RT-PCR. Rotavirus RNA extracted by using the RNaid kit may be sheared or somehow damaged by the manual extraction procedure of this kit with reduced detection efficiency of larger RNA molecules. Automated methods such as the MagNA Pure Compact and KingFisher Flex may damage RNA less than manual methods. Although limitations for detection at low virus concentrations may not be of concern when testing samples from persons with acute rotavirus gastroenteritis, from whom rotavirus typically is shed at very high concentrations in stool (approximately 10^10^--10^11^  particles/g of stool) ([@bib0220]), this limitation would be important when choosing a method to extract samples from convalescent cases or healthy controls in which the viral concentration would be expected to be much lower.

Two limitations of this study should be noted. Because of the differences in extraction products (total nucleic acid or RNA), as well the presence of carrier RNA in the QIAamp Viral Mini RNA kit extracts, no attempt was made to measure directly and compare the quantity of the nucleic acid in the sample extracts tested. Also, no internal positive control was included in the extractions. Another limitation of this study was the lack of an encapsulated RNA control that could be spiked into stool, without RNA degradation by nucleases present in feces, and detected post-extraction by qRT-PCR and RT-PCR. Efforts to develop such a control are currently underway.

In summary, this study reports the most extensive evaluation to date of extraction platforms for the purification of rotavirus RNA from stool samples. The findings of this study will be very useful for laboratories in the selection of extraction methods for detection of rotavirus RNA in stool and the development of future protocols for rotavirus testing and surveillance.

We wish to thank Jon Gentsch for helpful discussions and guidance and Mary McCauley for editorial assistance. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Names of specific vendors, manufacturers, or products are included for public health and informational purposes; inclusion does not imply endorsement of the vendors, manufacturers, or products by the Centers for Disease Control and Prevention or the US Department of Health and Human Services.

[^1]: These RNA extraction kits do not utilize a DNase treatment step and thus the extracted product may also contain DNA.

[^2]: Total nucleic acid.

[^3]: *C*~T~ values obtained for RNaid kit extracts were significantly lower than those obtained for the easyMAG (*P* \< 0.001), miniMAG (*P* \< 0.001), and QIAamp (*P* \< 0.01) kits.

[^4]: *C*~T~ values obtained for MagNA Pure Compact extracts were significantly lower than those obtained for the miniMAG (*P* \< 0.05).

[^5]: *C*~T~ values obtained for KingFisher Flex extracts were significantly lower than those obtained for the easyMAG (*P* \< 0.05) and miniMAG (*P* \< 0.01).

[^6]: Cost calculated in 2012.
